The Phase 3 clinical trial results of the promising COVID-19 vaccine of Johnson & Johnson are expected this month. The Dutch electron microscopy facility NeCEN helped develop the company's vaccine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback